InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Monday, 12/17/2012 11:07:53 AM

Monday, December 17, 2012 11:07:53 AM

Post# of 130507
Don't focus on .20 by 12/31.

Focus on $1.00 or higher when a "big pharma" development partnership is announced in 2013.

If the co-founder of Amgen states that the company's patented MANF technology is one of the best candidates that he's ever seen to generate billions of dollars in future revenues then I'm inclined to believe him and buy AMBS shares at the current depressed price.

I hope others are also taking advantage of the market not yet knowing about the tremendous upside that the company offers.

The current share price is "free" money.